• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    77,691
    Total Members
    3,093
    Most Online
    JHAllen
    Newest Member
    JHAllen
    Joined
  • 0

    Quaker Launches Gluten-free Oat So Simple and Traditional Rolled Oats in UK


    Jefferson Adams
    Image Caption: Quaker has launched numerous new gluten-free products in the UK. Photo: CC--Amber Kennedy

    Celiac.com 12/28/2016 - Quaker Oats UK has launched several gluten-free oat products, including a free-from variant and a yogurt-based breakfast pouch range. Available since late September, the new gluten-free offering comes in a 510g can of Traditional Rolled Oats, and a 350g box of 10 Oat So Simple packets.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    "Leading a gluten-free lifestyle is important and necessary for some people, and so Quaker has created options to meet consumer demand," says PepsiCo's Jeremy Gibson, marketing director, nutrition.

    The launch follows the introduction earlier this month of Oat & Fruit Breakfast, an on-the-go pouch line made with fruit purée and natural yogurt that comes in three flavors: Red Fruits, Apple & Cinnamon, and Blueberry.

    The products will be sold exclusively at UK's Tesco stores, and will be promoted with an aggressive social media campaign and in-store marketing.

    Calling Oat & Fruit Breakfast "unique to the market" Duncan McKay, PepsiCo's senior marketing manager for grains UK, expressed excitement over the new product range, which come "as demand for convenient breakfast options is at a peak."

    Stay tuned for more information on gluten-free products from Quaker, and other manufacturers.

    0


    User Feedback

    Recommended Comments

    No way and never never never will I ever eat oats again!

    Share this comment


    Link to comment
    Share on other sites


    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Ads by Google:

  • About Me

    Jefferson Adams is a freelance writer living in San Francisco. He has covered Health News for Examiner.com, and provided health and medical content for Sharecare.com. His work has appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate, among others.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   2 Members, 0 Anonymous, 275 Guests (See full list)

  • Related Articles

    Jefferson Adams
    Celiac.com 03/31/2016 - Kellogg has announced that gluten-free versions of its Corn Flakes and Special K cereals will mark its gluten-free debut into the Australian cereal market.
    Kellogg calls the products a response to growing demand for gluten-free products from consumers with celiac disease and gluten intolerance. "We continue to see a growing number of consumers, including coeliac disease sufferers, requesting gluten free alternatives to our popular cereals."
    In formulating their new products, Kellogg set out to combat a perception in the Australian cereal market that gluten-free cereals routinely failed to "deliver a great taste experience that's consistent with products containing gluten," said Janine Brooker, portfolio marketing manager for Kellogg Australia.
    Kellogg "…wanted to make sure that our gluten-free Corn Flakes and Special K taste just as good as the original classics," Brooker added.
    Kellogg's Corn Flakes Gluten Free and Special K Gluten Free are available in 330g boxes at supermarkets across Australia.

    Jefferson Adams
    Celiac.com 08/12/2016 - Cereal-maker General Mills has announced the debut of five varieties of gluten-free cereals in Canada by the end of summer.
    The five varieties include Original Cheerios, Honey Nut Cheerios, Multi-Grain Cheerios, Apple Cinnamon Cheerios and Chocolate Cheerios.
    General Mills is excited to offer gluten-free Canadians more gluten-free cereal options, says Emma Eriksson, director of marketing for General Mills Canada, said in a release.
    She adds that "gluten-free Cheerios products will maintain the same great taste that consumers love at the same price they're used to."
    All gluten-free Cheerios products will be clearly labelled "gluten free" on the front of the box.
    Gluten-free Cheerios was first introduced in the U.S. last summer. Gluten-free Cheerios products join other gluten-free cereals already sold by General Mills, including Rice Chex, Chex Honey Nut and Cinnamon Chex, with Chocolate Chex also launching in Canada this summer.
    Read more: insidetoronto.com

    Jefferson Adams
    Celiac.com 08/17/2016 - Cereal-maker General Mills is looking to patent method and system for manufacturing gluten-free oats.
    The application for patent protection covers numerous mechanical separation processes on a variety of grains, including oat grains and gluten-containing grains, using, among other things, width grading steps, multiple length grading steps, aspirating steps and a potential de-bearding step.
    Federal labeling regulations require products labeled 'gluten-free' to have gluten levels below 20 ppm. The process allow the production of oat grains with gluten levels below 20 parts per million, and optimally at 10 ppm.
    The resulting oats are gluten-free oats and suitable for use in a variety of gluten-free oat food products, including cereal and granola products, according to the patent US 2016/0207048 A1, filed on July 21st 2016.

    Mechanical separation techniques, such as these covered by the patent application, have the potential to be highly efficient and economical. The patent does not mention more expensive optical systems.
    Oats are naturally gluten-free, but, according to the patent, "oats cultivated in North America, Europe and other parts of the world commonly are contaminated by gluten-containing grains such as wheat, barley, rye and triticale."
    Contamination can result from rotating grains on the same crop land, and from harvesting, transporting, storing and merchandising.
    General Mills experienced problems with wheat contamination of gluten-free products last year, when they were forced to recall an estimated 1.8 million boxes of gluten-free Cheerios and Honey Nut Cheerios at its Lodi, Calif., plant. The product was contaminated with gluten. However, the company has maintained that the gluten contamination was due to an employee processing error, not any defect in their grain sorting equipment covered under the patent protection.
    Stay tuned to find out if General Mills receives their patent, and if their process has a significant impact on the quality, availability and cost of gluten-free oats.

  • Recent Articles

    Jefferson Adams
    Celiac.com 06/21/2018 - Would you buy a house advertised as ‘gluten-free’? Yes, there really is such a house for sale. 
    It seems a Phoenix realtor Mike D’Elena is hoping that his trendy claim will catch the eye of a buyer hungry to avoid gluten, or, at least one with a sense of humor. D’Elena said he crafted the ads as a way to “be funny and to draw attention.” The idea, D’Elena said, is to “make it memorable.” 
    Though D’Elena’s marketing seeks to capitalizes on the gluten-free trend, he knows Celiac disease is a serious health issue for some people. “[W]e’re not here to offend anybody….this is just something we're just trying to do to draw attention and do what's best for our clients," he said. 
    Still, the signs seem to be working. D'elena had fielded six offers within a few days of listing the west Phoenix home.
    "Buying can sometimes be the most stressful thing you do in your entire life so why not have some fun with it," he said. 
    What do you think? Clever? Funny?
    Read more at Arizonafamily.com.

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.